Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200479450> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W3200479450 abstract "Background: Ovarian cancer is the leading cause of death caused by genital cancers. One of the most common treatments for this type of cancer is chemotherapy by cisplatin, which induces apoptosis in cancer cells. Apoptosis is a type of physiological cell death. Cisplatin chemotherapy usually has several side effects and cellular resistance to cisplatin is a common incidence. In order to overcome these problems, the use of combination therapies using natural substances has been considered. Fisetin is a flavonoid with anti-cancer activity which induces apoptosis. In this study, the apoptosis induced by cisplatin along with Fisetin in cisplatin-resistant ovarian cancer cell line (A2780) was investigated.
 Methods: In the present experimental study, the effect of combined use of Fisetin and cisplatin on ovarian cancer cell lines (A2780) was investigated by using MTT assay. Cell death was also determined by DAPI, acridine orange/propidium iodide, and Annexin/PI assay. Apoptotic gene expression of Bax, BCL-2, caspase 3, and caspase 9 was also assessed by real time PCR.
 Results: The results of MTT assay indicated that the combined treatment of Fisetin and cisplatin effectively inhibits proliferation of A2780 cells. The results of DAPI staining showed that fragmentation of chromatin in cells occurred in the combined treatment. Acridine orange-propidium iodide staining and Annexin/PI staining showed an increase in the rate of apoptotic cells in cells under combined treatment. The results of the study regarding changes in gene expression also indicated that Bax pro-apoptotic gene expression and BCL-2 anti-apoptotic gene expression increased in cells under treatment; moreover, gene expression of caspases 3 and 9 significantly increased as well.
 Conclusion: According to the findings of this study, the combined use of cisplatin and Fisetin increases the induction of apoptosis in cisplatin-resistant ovarian cancer cells (A2780); therefore, the combined use of cisplatin and Fisetin can be considered a promising strategy in the treatment of ovarian cancer." @default.
- W3200479450 created "2021-09-27" @default.
- W3200479450 creator A5006756655 @default.
- W3200479450 creator A5029209050 @default.
- W3200479450 creator A5068408355 @default.
- W3200479450 date "2021-09-21" @default.
- W3200479450 modified "2023-09-24" @default.
- W3200479450 title "Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin- Resistant Ovarian Cancer Cells (A2780)" @default.
- W3200479450 doi "https://doi.org/10.18502/ajmb.v13i4.7202" @default.
- W3200479450 hasPublicationYear "2021" @default.
- W3200479450 type Work @default.
- W3200479450 sameAs 3200479450 @default.
- W3200479450 citedByCount "2" @default.
- W3200479450 countsByYear W32004794502022 @default.
- W3200479450 countsByYear W32004794502023 @default.
- W3200479450 crossrefType "journal-article" @default.
- W3200479450 hasAuthorship W3200479450A5006756655 @default.
- W3200479450 hasAuthorship W3200479450A5029209050 @default.
- W3200479450 hasAuthorship W3200479450A5068408355 @default.
- W3200479450 hasConcept C121608353 @default.
- W3200479450 hasConcept C153911025 @default.
- W3200479450 hasConcept C185592680 @default.
- W3200479450 hasConcept C190283241 @default.
- W3200479450 hasConcept C2775934118 @default.
- W3200479450 hasConcept C2776694085 @default.
- W3200479450 hasConcept C2777376040 @default.
- W3200479450 hasConcept C2777527632 @default.
- W3200479450 hasConcept C2778004101 @default.
- W3200479450 hasConcept C2778239845 @default.
- W3200479450 hasConcept C2779054382 @default.
- W3200479450 hasConcept C2779102032 @default.
- W3200479450 hasConcept C2780427987 @default.
- W3200479450 hasConcept C2780783641 @default.
- W3200479450 hasConcept C31573885 @default.
- W3200479450 hasConcept C502942594 @default.
- W3200479450 hasConcept C54355233 @default.
- W3200479450 hasConcept C55493867 @default.
- W3200479450 hasConcept C86803240 @default.
- W3200479450 hasConcept C88634738 @default.
- W3200479450 hasConcept C96232424 @default.
- W3200479450 hasConceptScore W3200479450C121608353 @default.
- W3200479450 hasConceptScore W3200479450C153911025 @default.
- W3200479450 hasConceptScore W3200479450C185592680 @default.
- W3200479450 hasConceptScore W3200479450C190283241 @default.
- W3200479450 hasConceptScore W3200479450C2775934118 @default.
- W3200479450 hasConceptScore W3200479450C2776694085 @default.
- W3200479450 hasConceptScore W3200479450C2777376040 @default.
- W3200479450 hasConceptScore W3200479450C2777527632 @default.
- W3200479450 hasConceptScore W3200479450C2778004101 @default.
- W3200479450 hasConceptScore W3200479450C2778239845 @default.
- W3200479450 hasConceptScore W3200479450C2779054382 @default.
- W3200479450 hasConceptScore W3200479450C2779102032 @default.
- W3200479450 hasConceptScore W3200479450C2780427987 @default.
- W3200479450 hasConceptScore W3200479450C2780783641 @default.
- W3200479450 hasConceptScore W3200479450C31573885 @default.
- W3200479450 hasConceptScore W3200479450C502942594 @default.
- W3200479450 hasConceptScore W3200479450C54355233 @default.
- W3200479450 hasConceptScore W3200479450C55493867 @default.
- W3200479450 hasConceptScore W3200479450C86803240 @default.
- W3200479450 hasConceptScore W3200479450C88634738 @default.
- W3200479450 hasConceptScore W3200479450C96232424 @default.
- W3200479450 hasLocation W32004794501 @default.
- W3200479450 hasOpenAccess W3200479450 @default.
- W3200479450 hasPrimaryLocation W32004794501 @default.
- W3200479450 hasRelatedWork W11467293 @default.
- W3200479450 hasRelatedWork W1366240 @default.
- W3200479450 hasRelatedWork W13825660 @default.
- W3200479450 hasRelatedWork W4152498 @default.
- W3200479450 hasRelatedWork W5363639 @default.
- W3200479450 hasRelatedWork W5979993 @default.
- W3200479450 hasRelatedWork W7268927 @default.
- W3200479450 hasRelatedWork W8056224 @default.
- W3200479450 hasRelatedWork W8061009 @default.
- W3200479450 hasRelatedWork W9793405 @default.
- W3200479450 isParatext "false" @default.
- W3200479450 isRetracted "false" @default.
- W3200479450 magId "3200479450" @default.
- W3200479450 workType "article" @default.